Advisors Asset Management
IPSC icon

Advisors Asset Management’s Century Therapeutics IPSC Stock Holding History

Advisors Asset Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,315
Closed -$20.4K – 1437
2026
Q2 		$20.4K Buy
8,315
+2
+0% +$5 ﹤0.01% 1345
2026
Q1 		$18.8K Hold
8,313
– – ﹤0.01% 1358
2025
Q4 		$8.27K Sell
8,313
-99
-1% -$60 ﹤0.01% 1384
2025
Q3 		$4.19K Sell
8,412
-86
-1% -$46 ﹤0.01% 1406
2025
Q2 		$4.75K Buy
+8,498
New +$4.56K ﹤0.01% 1410

Other funds holding IPSC

Versant Venture Management
Versant Venture Management San Francisco, California $109M AUM 43.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Spruce Street Capital
Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Advisors Asset Management's IPSC Position: Q3 2026 in Review

Advisors Asset Management sold out of Century Therapeutics (IPSC) in Q3 2026, closing a stake of 8,315 shares — an estimated $20.4K sold.

Advisors Asset Management first reported a position in IPSC in Q2 2025 and held it in 5 quarters. The position peaked at $20.4K in Q2 2026. 58 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Advisors Asset Management reported no remaining Century Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Advisors Asset Management sold 8,315 Century Therapeutics shares in Q3 2026, an estimated $20.4K.
  • Advisors Asset Management first reported a position in Century Therapeutics in Q2 2025 and held it in 5 quarters.
  • Advisors Asset Management's Century Therapeutics position peaked at $20.4K in Q2 2026.
  • 58 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Advisors Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.